The final, formatted version of the article will be published soon. The use of glucagon-like peptide-1 (GLP-1) receptor agonists by young populations is rapidly increasing worldwide, thereby exposing ...

A NEW phase 3 trial suggests that mazdutide, a once-weekly dual glucagon and glucagon-like peptide-1 (GLP-1) receptor agonist, may offer enhanced glycaemic control and weight reduction compared with ...

Michigan State transfer linebacker Aisea Moa has reportedly received an offer from rival Michigan. Moa played in 11 games for the Spartans this season, recording 12 tackles. He has one year of ...

Tirzepatide noninferior to dulaglutide with respect to composite of death from cardiovascular causes, myocardial infarction, or stroke. (HealthDay News) — Tirzepatide is noninferior to dulaglutide ...

Please provide your email address to receive an email when new articles are posted on . Semaglutide is approved by the FDA for slowing the progression of chronic kidney disease. Liraglutide and ...

Michigan State is losing another player on the defensive side of the ball to the transfer portal, with Aisea Moa making the decision to transfer away from the Spartans program. Moa, who came to MSU in ...

One subscription: The best Michigan Wolverines coverage and community, and all access to the On3 College Sports Network.

Tirzepatide is noninferior to dulaglutide with respect to a composite of death from cardiovascular (CV) causes, myocardial infarction, or stroke among patients with type 2 diabetes and atherosclerotic ...

One subscription: The best Michigan Wolverines coverage and community, and all access to the On3 College Sports Network.